ENDS EVALI VALI THCVALI: Difference between revisions
| Line 43: | Line 43: | ||
**Citation: Katherine East, Jessica L Reid, Robin Burkhalter, Olivia A Wackowski, James F Thrasher, Harry Tattan-Birch, Christian Boudreau, Maansi Bansal-Travers, Alex C Liber, Ann McNeill, David Hammond, Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’), Nicotine & Tobacco Research, Volume 24, Issue 9, September 2022, Pages 1386–1395, https://doi.org/10.1093/ntr/ntac088 | **Citation: Katherine East, Jessica L Reid, Robin Burkhalter, Olivia A Wackowski, James F Thrasher, Harry Tattan-Birch, Christian Boudreau, Maansi Bansal-Travers, Alex C Liber, Ann McNeill, David Hammond, Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’), Nicotine & Tobacco Research, Volume 24, Issue 9, September 2022, Pages 1386–1395, https://doi.org/10.1093/ntr/ntac088 | ||
*** Acknowledgment: This work was supported by a P01 Grant (1P01CA200512) from the US National Institutes of Health (NIH). Additional support was provided by a Canadian Institutes of Health Research (CIHR)–Public Health Agency of Canada (PHAC) Applied Public Health Research Chair (DH). The February 2020 Wave of the ITC Youth Tobacco and Vaping Survey was funded by a contribution from Health Canada’s Substance Use and Addictions Program (SUAP). KE is the recipient of Fellowship funding from the UK Society for the Study of Addiction (SSA). KE and AM also acknowledge support from Cancer Research UK (RE12936). Contributions by OAW were supported in part by the NIH (R37CA222002). The views expressed herein do not necessarily represent the views of any of the funding agencies. DH has served as a paid expert witness in legal challenges against tobacco and vaping companies. | *** Acknowledgment: This work was supported by a P01 Grant (1P01CA200512) from the US National Institutes of Health (NIH). Additional support was provided by a Canadian Institutes of Health Research (CIHR)–Public Health Agency of Canada (PHAC) Applied Public Health Research Chair (DH). The February 2020 Wave of the ITC Youth Tobacco and Vaping Survey was funded by a contribution from Health Canada’s Substance Use and Addictions Program (SUAP). KE is the recipient of Fellowship funding from the UK Society for the Study of Addiction (SSA). KE and AM also acknowledge support from Cancer Research UK (RE12936). Contributions by OAW were supported in part by the NIH (R37CA222002). The views expressed herein do not necessarily represent the views of any of the funding agencies. DH has served as a paid expert witness in legal challenges against tobacco and vaping companies. | ||
===2021: [https://www.qeios.com/read/ZGVHM7.3 The outbreak of lung injuries often known as "EVALI" was nothing to do with nicotine vaping]=== | |||
*'''An examination of the evidence shows that EVALI cannot have been caused by nicotine vaping. The characteristics of the lung injury outbreak are consistent with localised supply chain contamination. The contaminant has been identified and is known to be Vitamin E Acetate. This had been used as a thickener or cutting agent in illicit Tetrahydrocannabinol (THC) cannabis vape pens. This agent cannot be mixed with nicotine vaping liquids and would serve no useful purpose if it could be. No other cause or causal agent has been identified that would both implicate nicotine liquids and be consistent with the geographical and temporal pattern of the lung injury outbreak.''' | |||
**Citation: Clive Bates. (2021). The outbreak of lung injuries often known as "EVALI" was nothing to do with nicotine vaping. Qeios. doi:10.32388/ZGVHM7.3. | |||
==Articles, Op-Eds, Blogs, Media== | ==Articles, Op-Eds, Blogs, Media== | ||